-+ 0.00%
-+ 0.00%
-+ 0.00%

BICARA THERAPEUTICS INC - PHASE 1B STUDY SHOWS DEEP, DURABLE RESPONSES AND WELL-TOLERATED SAFETY PROFILE

Reuters·05/21/2026 21:08:16

Please log in to view news